China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026)

China Pharma Holdings (CPHI) has reported Change in Inventory for 17 consecutive years, with -$272929.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory fell 65.61% year-over-year to -$272929.0; the trailing twelve-month figure through Jun 2026 stood at -$788751.0 (up 34.77% YoY), and the FY2025 full-year result was -$589761.0, up 63.3% from the prior year.
• Change in Inventory eased to -$272929.0 in Q2 2026 per CPHI's latest filing, from -$247492.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $552686.0 in Q1 2023 and bottomed at -$582187.0 in Q3 2022.
• Historically, Change in Inventory has averaged -$188284.2 across 5 years, with a median of -$229021.5 in 2025.
• The widest YoY moves for Change in Inventory: up 311.81% in 2022, down 533.35% in 2022.
• Over 5 years, Change in Inventory stood at -$192902.0 in 2022, then slumped by 34.09% to -$258659.0 in 2023, then sank by 97.56% to -$510996.0 in 2024, then jumped by 58.8% to -$210551.0 in 2025, then dropped by 29.63% to -$272929.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$272929.0, -$247492.0, and -$210551.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.